Abstract
Bioimpedance analysis (BIA) has been demanded for the assessment of appendicular skeletal muscle mass (ASM) in clinical and epidemiological settings. This study aimed to validate BIA equations for predicting ASM in the standing and supine positions; externally to cross-validate the new and published and built-in BIA equations for group and individual predictive accuracy; and to assess the overall agreement between the measured and predicted ASM index as sarcopenia diagnosis. In total, 199 healthy older adults completed the measurements of multifrequency BIA (InBody770 and InBodyS10) and dual-energy X-ray absorptiometry (DXA). Multiple regression analysis was used to validate the new multifrequency bioelectrical impedance analysis (MF-BIA) prediction equations. Each MF-BIA equation in the standing and supine position developed in the entire group included height2/resistance, sex, and reactance as predictors (R2 = 92.7% and 92.8%, SEE = 1.02 kg and 1.01 kg ASM for the standing and supine MF-BIA). The new MF-BIA equations had a specificity positive predictive value and negative predictive value of 85% or more except for a sensitivity of about 60.0%. The new standing and supine MF-BIA prediction equation are useful for epidemiological and field settings as well as a clinical diagnosis of sarcopenia. Future research is needed to improve the sensitivity of diagnosis of sarcopenia using MF-BIA.
Highlights
Sarcopenia is a condition that involves a loss of skeletal muscle mass in aging
The between-groups had no difference in all the variables and the between-sex had no difference in Age, BMI, and Xc
The sensitivity, specificity and overall agreement for the diagnosis of sarcopenia by the two new prediction equations were reasonably applicable to clinical diagnosis, except that a little caution on sensitivity is required
Summary
Sarcopenia is a condition that involves a loss of skeletal muscle mass in aging. Due to this drastic reduction in muscle mass, physical functional impairment and disability occur [1]. Organization (WHO) assigned the disease code ICD-10-CM (M62.84) to sarcopenia [2]. Sarcopenia research is at least 15–20 years behind osteopenia or osteoporosis research [3]. Res. Public Health 2020, 17, 5847; doi:10.3390/ijerph17165847 www.mdpi.com/journal/ijerph
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
